430 related articles for article (PubMed ID: 33351507)
1. Fibroblast Activation Protein Inhibitor PET/CT: A Promising Molecular Imaging Tool.
Sharma P; Singh SS; Gayana S
Clin Nucl Med; 2021 Mar; 46(3):e141-e150. PubMed ID: 33351507
[TBL] [Abstract][Full Text] [Related]
2.
Giesel FL; Kratochwil C; Lindner T; Marschalek MM; Loktev A; Lehnert W; Debus J; Jäger D; Flechsig P; Altmann A; Mier W; Haberkorn U
J Nucl Med; 2019 Mar; 60(3):386-392. PubMed ID: 30072500
[TBL] [Abstract][Full Text] [Related]
3. Targeting Fibroblast Activation Protein: Radiosynthesis and Preclinical Evaluation of an
Toms J; Kogler J; Maschauer S; Daniel C; Schmidkonz C; Kuwert T; Prante O
J Nucl Med; 2020 Dec; 61(12):1806-1813. PubMed ID: 32332144
[TBL] [Abstract][Full Text] [Related]
4. Clinical summary of fibroblast activation protein inhibitor-based radiopharmaceuticals: cancer and beyond.
Li M; Younis MH; Zhang Y; Cai W; Lan X
Eur J Nucl Med Mol Imaging; 2022 Jul; 49(8):2844-2868. PubMed ID: 35098327
[TBL] [Abstract][Full Text] [Related]
5.
Kratochwil C; Flechsig P; Lindner T; Abderrahim L; Altmann A; Mier W; Adeberg S; Rathke H; Röhrich M; Winter H; Plinkert PK; Marme F; Lang M; Kauczor HU; Jäger D; Debus J; Haberkorn U; Giesel FL
J Nucl Med; 2019 Jun; 60(6):801-805. PubMed ID: 30954939
[TBL] [Abstract][Full Text] [Related]
6. Design and Development of
Lindner T; Altmann A; Krämer S; Kleist C; Loktev A; Kratochwil C; Giesel F; Mier W; Marme F; Debus J; Haberkorn U
J Nucl Med; 2020 Oct; 61(10):1507-1513. PubMed ID: 32169911
[TBL] [Abstract][Full Text] [Related]
7. State-of-the-art of FAPI-PET imaging: a systematic review and meta-analysis.
Sollini M; Kirienko M; Gelardi F; Fiz F; Gozzi N; Chiti A
Eur J Nucl Med Mol Imaging; 2021 Dec; 48(13):4396-4414. PubMed ID: 34173007
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic and Therapeutic Application of Fibroblast Activation Protein Inhibitors in Oncologic and Nononcologic Diseases.
Nakayama M; Hope TA; Salavati A
Cancer J; 2024 May-Jun 01; 30(3):210-217. PubMed ID: 38753756
[TBL] [Abstract][Full Text] [Related]
9. Fibroblast Activation Protein Inhibitor (FAPI) PET Imaging in Sarcomas: A New Frontier in Nuclear Medicine.
Giammarile F; Knoll P; Paez D; Estrada Lobato E; Calapaquí Terán AK; Delgado Bolton RC
Semin Nucl Med; 2024 May; 54(3):340-344. PubMed ID: 38365545
[TBL] [Abstract][Full Text] [Related]
10. Fibroblast Activation Protein Inhibitor Tracers and Their Preclinical, Translational, and Clinical Status in China.
Zhao L; Kang F; Pang Y; Fang J; Sun L; Wu H; Lan X; Wang J; Chen H
J Nucl Med; 2024 May; 65(Suppl 1):4S-11S. PubMed ID: 38719234
[TBL] [Abstract][Full Text] [Related]
11. IDH-wildtype glioblastomas and grade III/IV IDH-mutant gliomas show elevated tracer uptake in fibroblast activation protein-specific PET/CT.
Röhrich M; Loktev A; Wefers AK; Altmann A; Paech D; Adeberg S; Windisch P; Hielscher T; Flechsig P; Floca R; Leitz D; Schuster JP; Huber PE; Debus J; von Deimling A; Lindner T; Haberkorn U
Eur J Nucl Med Mol Imaging; 2019 Nov; 46(12):2569-2580. PubMed ID: 31388723
[TBL] [Abstract][Full Text] [Related]
12. Development of Fibroblast Activation Protein-Targeted Radiotracers with Improved Tumor Retention.
Loktev A; Lindner T; Burger EM; Altmann A; Giesel F; Kratochwil C; Debus J; Marmé F; Jäger D; Mier W; Haberkorn U
J Nucl Med; 2019 Oct; 60(10):1421-1429. PubMed ID: 30850501
[TBL] [Abstract][Full Text] [Related]
13. Will FAPI PET/CT Replace FDG PET/CT in the Next Decade? Counterpoint-No, Not So Fast!
Moradi F; Iagaru A
AJR Am J Roentgenol; 2021 Feb; 216(2):307-308. PubMed ID: 32755204
[No Abstract] [Full Text] [Related]
14. The Role of Fibroblast Activation Protein Ligands in Oncologic PET Imaging.
Dendl K; Schlittenhardt J; Staudinger F; Kratochwil C; Altmann A; Haberkorn U; Giesel FL
PET Clin; 2021 Jul; 16(3):341-351. PubMed ID: 34053578
[TBL] [Abstract][Full Text] [Related]
15. Will FAPI PET/CT Replace FDG PET/CT in the Next Decade? Point-An Important Diagnostic, Phenotypic, and Biomarker Role.
Calais J; Mona CE
AJR Am J Roentgenol; 2021 Feb; 216(2):305-306. PubMed ID: 32755205
[No Abstract] [Full Text] [Related]
16. Head-to-Head Comparison of Fibroblast Activation Protein Inhibitors (FAPI) Radiotracers versus [
Treglia G; Muoio B; Roustaei H; Kiamanesh Z; Aryana K; Sadeghi R
Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681850
[TBL] [Abstract][Full Text] [Related]
17. Development of Quinoline-Based Theranostic Ligands for the Targeting of Fibroblast Activation Protein.
Lindner T; Loktev A; Altmann A; Giesel F; Kratochwil C; Debus J; Jäger D; Mier W; Haberkorn U
J Nucl Med; 2018 Sep; 59(9):1415-1422. PubMed ID: 29626119
[TBL] [Abstract][Full Text] [Related]
18. Fibroblast Activation Protein-Targeted PET/CT with
Luo Y; Pan Q; Yang H; Peng L; Zhang W; Li F
J Nucl Med; 2021 Feb; 62(2):266-271. PubMed ID: 32513902
[TBL] [Abstract][Full Text] [Related]
19. Fibroblast activation protein-based theranostics in cancer research: A state-of-the-art review.
Zhao L; Chen J; Pang Y; Fu K; Shang Q; Wu H; Sun L; Lin Q; Chen H
Theranostics; 2022; 12(4):1557-1569. PubMed ID: 35198057
[TBL] [Abstract][Full Text] [Related]
20. Disentangling inflammatory from fibrotic disease activity by fibroblast activation protein imaging.
Schmidkonz C; Rauber S; Atzinger A; Agarwal R; Götz TI; Soare A; Cordes M; Prante O; Bergmann C; Kleyer A; Ritt P; Maschauer S; Hennig P; Toms J; Köhner M; Manger B; Stone JH; Haberkorn U; Baeuerle T; Distler JHW; Agaimy A; Kuwert T; Schett G; Ramming A
Ann Rheum Dis; 2020 Nov; 79(11):1485-1491. PubMed ID: 32719042
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
